PDF
File
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Kalender
| 2021-02-25 | Kvartalsrapport 2021-Q3 |
| 2020-11-26 | Kvartalsrapport 2021-Q2 |
| 2020-08-26 | Årsstämma 2020 |
| 2020-08-26 | Kvartalsrapport 2021-Q1 |
| 2020-05-29 | Bokslutskommuniké 2020 |
| 2020-02-21 | Halvårsutdelning EKTA B 0.90 SEK |
| 2020-02-20 | Kvartalsrapport 2020-Q3 |
| 2019-11-28 | Kvartalsrapport 2020-Q2 |
| 2019-08-23 | Halvårsutdelning EKTA B 0.90 SEK |
| 2019-08-22 | Årsstämma 2019 |
| 2019-08-22 | Kvartalsrapport 2020-Q1 |
| 2019-05-29 | Bokslutskommuniké 2019 |
| 2019-03-01 | Halvårsutdelning EKTA B 0.70 SEK |
| 2019-02-22 | Kvartalsrapport 2019-Q3 |
| 2018-11-29 | Kvartalsrapport 2019-Q2 |
| 2018-08-31 | Halvårsutdelning EKTA B 0.70 SEK |
| 2018-08-30 | Årsstämma 2018 |
| 2018-08-30 | Kvartalsrapport 2019-Q1 |
| 2018-06-01 | Bokslutskommuniké 2018 |
| 2018-03-02 | Kvartalsrapport 2018-Q3 |
| 2018-02-22 | Halvårsutdelning EKTA B 0.50 SEK |
| 2017-11-30 | Kvartalsrapport 2018-Q2 |
| 2017-08-24 | Halvårsutdelning EKTA B 0.50 SEK |
| 2017-08-23 | Kvartalsrapport 2018-Q1 |
| 2017-08-23 | Årsstämma 2017 |
| 2017-06-01 | Bokslutskommuniké 2017 |
| 2017-03-03 | Halvårsutdelning EKTA B 0.25 SEK |
| 2017-03-01 | Kvartalsrapport 2017-Q3 |
| 2016-12-01 | Kvartalsrapport 2017-Q2 |
| 2016-09-26 | Kapitalmarknadsdag 2016 |
| 2016-09-02 | Halvårsutdelning EKTA B 0.25 SEK |
| 2016-09-01 | Kvartalsrapport 2017-Q1 |
| 2016-09-01 | Årsstämma 2016 |
| 2016-06-01 | Bokslutskommuniké 2016 |
| 2016-03-02 | Kvartalsrapport 2016-Q3 |
| 2015-12-03 | Kvartalsrapport 2016-Q2 |
| 2015-09-02 | Ordinarie utdelning EKTA B 0.50 SEK |
| 2015-09-01 | Årsstämma 2015 |
| 2015-09-01 | Kvartalsrapport 2016-Q1 |
| 2015-06-02 | Bokslutskommuniké 2015 |
| 2015-03-04 | Kvartalsrapport 2015-Q3 |
| 2014-11-27 | Kvartalsrapport 2015-Q2 |
| 2014-11-27 | Analytiker möte 2014 |
| 2014-09-15 | Kapitalmarknadsdag 2014 |
| 2014-08-29 | Ordinarie utdelning EKTA B 1.50 SEK |
| 2014-08-29 | Bonusutdelning EKTA B 0.50 SEK |
| 2014-08-28 | Kvartalsrapport 2015-Q1 |
| 2014-08-28 | Analytiker möte 2015 |
| 2014-08-28 | Årsstämma 2014 |
| 2014-05-28 | Bokslutskommuniké 2014 |
| 2014-05-28 | Analytiker möte 2014 |
| 2014-02-27 | Kvartalsrapport 2014-Q3 |
| 2013-12-04 | Kvartalsrapport 2014-Q2 |
| 2013-09-23 | Kapitalmarknadsdag 2013 |
| 2013-09-04 | Ordinarie utdelning EKTA B 1.50 SEK |
| 2013-09-04 | Bonusutdelning EKTA B 0.50 SEK |
| 2013-09-03 | Kvartalsrapport 2014-Q1 |
| 2013-09-03 | Årsstämma 2013 |
| 2013-06-05 | Analytiker möte 2013 |
| 2013-06-05 | Bokslutskommuniké 2013 |
| 2013-03-05 | Kvartalsrapport 2013-Q3 |
| 2013-03-05 | Extra Bolagsstämma 2013 |
| 2012-12-04 | Kvartalsrapport 2013-Q2 |
| 2012-10-29 | Kapitalmarknadsdag 2012 |
| 2012-09-12 | Split EKTA B 1:4 |
| 2012-09-05 | Ordinarie utdelning EKTA B 5.00 SEK |
| 2012-09-03 | Årsstämma 2012 |
| 2012-09-03 | Kvartalsrapport 2013-Q1 |
| 2012-06-05 | Bokslutskommuniké 2012 |
| 2012-06-05 | Analytiker möte 2012 |
| 2012-04-02 | Extra Bolagsstämma 2012 |
| 2012-03-05 | Kvartalsrapport 2012-Q3 |
| 2011-12-02 | Kvartalsrapport 2012-Q2 |
| 2011-09-14 | Ordinarie utdelning EKTA B 4.00 SEK |
| 2011-09-13 | Årsstämma 2011 |
| 2011-09-13 | Kvartalsrapport 2012-Q1 |
| 2011-06-09 | Bokslutskommuniké 2011 |
| 2011-03-08 | Kvartalsrapport 2011-Q3 |
| 2010-12-07 | Kvartalsrapport 2011-Q2 |
| 2010-09-22 | Ordinarie utdelning EKTA B 3.00 SEK |
| 2010-09-21 | Kvartalsrapport 2011-Q1 |
| 2010-06-09 | Bokslutskommuniké 2010 |
| 2010-03-10 | Kvartalsrapport 2009-Q3 |
| 2009-12-10 | Kvartalsrapport 2009-Q2 |
| 2009-09-16 | Ordinarie utdelning EKTA B 2.00 SEK |
| 2009-09-15 | Årsstämma |
| 2009-09-15 | Kvartalsrapport 2009-Q1 |
| 2008-09-19 | Ordinarie utdelning EKTA B 1.75 SEK |
| 2007-09-26 | Ordinarie utdelning EKTA B 1.00 SEK |
| 2006-09-21 | Ordinarie utdelning EKTA B 1.00 SEK |
| 2005-10-17 | Split EKTA B 1:3 |
| 2005-09-22 | Ordinarie utdelning EKTA B 6.60 SEK |
| 2004-09-22 | Ordinarie utdelning EKTA B 0.00 SEK |
| 2003-09-23 | Ordinarie utdelning EKTA B 0.00 SEK |
| 2002-10-01 | Ordinarie utdelning EKTA B 0.00 SEK |
| 2001-09-28 | Ordinarie utdelning EKTA B 0.00 SEK |
| 2000-10-02 | Ordinarie utdelning EKTA B 0.00 SEK |
| 1999-09-23 | Ordinarie utdelning EKTA B 0.00 SEK |
Very strong order intake kick-starts the year
The year got off to a great start, demonstrating that innovation enables growth, with an increase in order intake by 32 percent. Underlying profitability increased, benefitting from higher net sales and improved gross margin. With this very encouraging quarter, we're in a strong position to continue creating value and strengthening our leadership in precision radiation medicine.
Richard Hausmann
President and CEO
- Gross order intake amounted to SEK 4,390 M (3,174), corresponding to a 32 percent organic growth.
- Net sales were SEK 3,228 M (2,819), corresponding to a 9 percent organic growth.
- Gross margin amounted to 42.6 (39.1) percent.
- EBITA increased by 16 percent to SEK 448 M (386), corresponding to an EBITA margin of 13.9 percent (13.7).
- Earnings per share was SEK 0.38 (0.43) before/after dilution.
- Cash flow after continuous investments was SEK -784 M (-542).
- 13 Elekta Unity orders booked in the quarter.
- At today's AGM the Board of Directors proposes a dividend of SEK 1.80 (1.40) per share for the fiscal year 2018/19 to be divided into two payments.
- Lionel Hadjadjeba has been hired and appointed as President MR-Linac Solutions to drive the commercialization of Elekta Unity.
- Verena Schiller has been appointed President Neuro Solutions to further develop our neuro business.
- Net sales growth of 8-10 percent, based on constant exchange rates.
- EBITA margin of around 19 percent.
[image]
1 After continuous investments
2 Before / after dilution
3 Compared to last fiscal year based on constant exchange rates
# # #
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time
This is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on August 22, 2019. (REGMAR)
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com (http://www.elekta.com) or follow @Elektaon Twitter.